131 related articles for article (PubMed ID: 25528842)
1. [The role of chronic gastritis in past medical history with NSAID administration in patients with osteoarthrosis].
Zak MIu
Lik Sprava; 2014 Nov; (11):93-7. PubMed ID: 25528842
[TBL] [Abstract][Full Text] [Related]
2. Medico-social value of osteoarthritis. secondary prevention and treatment of osteoarthritis in comorbidity with chronic gastritis.
Zak MY; Klymenko MO; Iakovenko NO; Grischenko GV
Wiad Lek; 2019; 72(5 cz 2):1064-1067. PubMed ID: 31175745
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
[TBL] [Abstract][Full Text] [Related]
4. Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis.
Girawan D; Abdurachman SA; Djumhana A; Roslia J; Pramudiyo R
Acta Med Indones; 2004; 36(4):202-6. PubMed ID: 15673949
[TBL] [Abstract][Full Text] [Related]
5. Safety of nimesulide, meloxicam and rofecoxib as alternative analgesics.
Karakaya G; Kalyoncu AF
Allergol Immunopathol (Madr); 2000; 28(6):319-21. PubMed ID: 11269899
[TBL] [Abstract][Full Text] [Related]
6. [Safety of specific cyclo-oxygenase 2 inhibitors].
Swaak AJ; Theunissen DJ
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1476-7; author reply 1477-8. PubMed ID: 11503322
[No Abstract] [Full Text] [Related]
7. Nimesulide and meloxicam are a safe alternative drugs for patients intolerant to nonsteroidal anti-inflammatory drugs.
Senna GE; Passalacqua G; Dama A; Crivellaro M; Schiappoli M; Bonadonna P; Canonica GW
Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):393-6. PubMed ID: 14768525
[TBL] [Abstract][Full Text] [Related]
8. Histological findings in gastric mucosa in patients treated with non-steroidal anti-inflammatory drugs.
Caselli M; LaCorte R; DeCarlo L; Aleotti A; Trevisani L; Ruina M; Trotta F; Alvisi V
J Clin Pathol; 1995 Jun; 48(6):553-5. PubMed ID: 7665699
[TBL] [Abstract][Full Text] [Related]
9. Meloxicam--a safer NSAID?
Drug Ther Bull; 1998 Aug; 36(8):62-4. PubMed ID: 9876404
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
Degner F; Sigmund R; Zeidler H
Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
[TBL] [Abstract][Full Text] [Related]
11. Ischaemic colitis in a patient taking meloxicam.
Garcia B; Ramaholimihaso F; Diebold MD; Cadiot G; Thiéfin G
Lancet; 2001 Mar; 357(9257):690. PubMed ID: 11247558
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
[TBL] [Abstract][Full Text] [Related]
13. Application of a propensity score to adjust for channelling bias with NSAIDs.
Morant SV; Pettitt D; MacDonald TM; Burke TA; Goldstein JL
Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):345-53. PubMed ID: 15170763
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
Layton D; Hughes K; Harris S; Shakir SA
Rheumatology (Oxford); 2003 Nov; 42(11):1354-64. PubMed ID: 12867585
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of adverse drug reaction from non-steroidal anti-inflammatory drugs in Shanghai patients with arthropathy.
Shi W; Wang YM; Li SL; Yan M; Li D; Chen BY; Cheng NN
Acta Pharmacol Sin; 2004 Mar; 25(3):357-65. PubMed ID: 15000891
[TBL] [Abstract][Full Text] [Related]
16. [Celecoxib and Tramadol as an alternative osteoarthrosis therapy in patients with NSAID gastropathy].
Lazebnik LB; Drozdov VN; Li IA; Kolomiets EV
Eksp Klin Gastroenterol; 2004; (5):21-5, 147. PubMed ID: 15770856
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
18. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs.
Forsyth SF; Guilford WG; Haslett SJ; Godfrey J
J Small Anim Pract; 1998 Sep; 39(9):421-4. PubMed ID: 9791828
[TBL] [Abstract][Full Text] [Related]
19. Meloxicam (Mobic) for osteoarthritis.
Med Lett Drugs Ther; 2000 May; 42(1079):47-8. PubMed ID: 10859731
[No Abstract] [Full Text] [Related]
20. Complications of nonsteroidal antiiflammatory drug gastropathy and use of gastric cytoprotection: experience at a tertiary care health center.
Bakowsky VS; Hanly JG
J Rheumatol; 1999 Jul; 26(7):1557-63. PubMed ID: 10405945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
